期刊文献+

青海藏族女性乳腺癌Ki67和nm23表达与预后的关系 被引量:2

Relationship of Ki67 and nm23 expressions and prognosis in Tibetan women with breast cancer
原文传递
导出
摘要 目的探讨Ki67和nm23在青海藏族女性乳腺癌的表达与临床病理的关系。方法采用SP免疫组化方法检测61例(A组)青海藏族女性乳腺癌石蜡包埋组织和82例(B组)乳腺增生病变中Ki67和nm23的表达。结果 A组Ki67和nm23蛋白阳性表达率分别为67.2%和65.6%,而B组分别为28.0%和90.2%(P<0.05)。Ki67表达与临床分期,腋窝淋巴结转移相关(P<0.05),nm23与临床分期、雌激素受体(ER)状态有关(P<0.05),而与肿瘤大小、病理类型、患者年龄、月经状况及孕酮受体(PR)状态无关。Ki67和nm23的蛋白表达无相关性。结论 Ki67高表达和nm23低表达与青海藏族女性乳腺癌的侵袭、转移及预后有关。 Objective To study the relationship of Ki67 and nm23 expressions and prognosis in Tibetan women with breast cancer.Methods The expressions of Ki67 and nm23 were detected with immunohistochemistry SP staining in 61 breast saples taken from women with breast cancer(group A) and 82 breast samples taken from women with breast hypertrophy.Results The expressions of Ki67 and nm23 were 67.2% and 65.6% in group A,respectively,which were significantly defferent from 28.0% and 90.2% in group B(P〈0.05).Ki67 expression was correlated to clinical staging and liphnode metastasis(P〈0.05) and nm23 expression was correlated to clinical staging and estrogen receptor(ER) status(P〈0.05),which were not to correlated to tumor size,pathological typing,age of patient,menstruation and progesterone receptor(PR) status.The expression of Ki67 was not correlated to that of nm23.Conclusion Ki67 overexpression and nm23 downexpression are associated with invasion,metastasis and prognosis of breast cancer in Tibetan women.
作者 邢国统
出处 《江苏医药》 CAS CSCD 北大核心 2011年第12期1433-1434,共2页 Jiangsu Medical Journal
关键词 乳腺癌 KI67 NM23 藏族 Breast cancer Ki67 nm23 Tibetan
  • 相关文献

参考文献5

二级参考文献22

  • 1毛杰,海健,张超杰,刘少华,唐利立,欧慧英,邬玉辉.双侧原发乳腺癌的流行病学特点与临床分析[J].中国现代医学杂志,2004,14(19):105-107. 被引量:9
  • 2黄俊辉,海健,李洋,唐利立,毛杰,申郑堂,胡铁辉.原发性乳腺癌组织中c-erbB-2和nm23的表达及其意义[J].中国普通外科杂志,2004,13(11):861-863. 被引量:11
  • 3姚先莹.进一步提高乳腺癌病理诊断和预后的检测水平[J].中华病理学杂志,1994,23(6):323-326. 被引量:11
  • 4[3]Pisani Al,Barbuto DA,Chen D,et al.HER-2ner,P53 and DNA analyses as prognoticators for survival in endometrial carcinoma[J].Obstet Gynecol,1995,85(5pt1):729-734.
  • 5[4]Lamb P,Grawford L.Characterization of the human p53 gene[J].Mol Cell Biol,1986,6(5): 1379-1385.
  • 6[6]Yu CC,Fletcher CD,Newman PL,et al.A comparison of proliferating cell nuclear antigen (PCNA) immunostaining nucleoar organizer region (AgNOR) staining,and histologic grading in gastrointestinal stromal tumours[J].J Pathol,1992,166(2): 147-152.
  • 7[7]Steeg PS,Bevilacqua G,Kopper L,et al.Evidence for a novel gene assiociated with low tumor metastatic potential[J].J Natl Cancer Inst,1988,80(3):200-204.
  • 8[8]Mao H,Liu H,Fu X,et al.Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer[J].Int J Oncol,2001,18(3): 587-591.
  • 9[9]Nakopoulou LL,Tsitsimelis D,Lazaris AC,et al.Nm23,c-erbB-2,and progesterone receptor expression in invasive breast cancer:correlation with clinicopathologic parameters[J].Cancer Detect Prev,1999,23(4):297.
  • 10[10]Berns EMJJ,Foekns JA,Van IL,et al.Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment[J].Gene,1995,159(8):11-18.

共引文献15

同被引文献17

  • 1吴萍.102例乳腺癌临床病理学分析[J].中国妇幼保健,2005,20(23):3070-3071. 被引量:3
  • 2姚文青,游玉梅,万芸.1109例乳腺癌X线影像病理学分型研究[J].现代临床医学生物工程学杂志,2006,12(2):126-128. 被引量:2
  • 3Akarolo-Anthony Sally N,Ogundiran Temidayo O,Adebamowo Clement A.Emerging breast cancer epidemic;evidence from Africa[J].Breast Cancer Res,2010,12(Z4):8.
  • 4Goldhirsch A,Wood WC,Coates AS,et al.Strategies for subtypes-dealing with the diversity of breast cancer:highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J].Ann Oncol,2011,22:1736-1747.
  • 5Chad A Livasy,Gamze Karaca,Rita Nanda,et al.Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma[J].Modern Pathol,2006,19(2):264-271.
  • 6Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
  • 7Yang HJ,Yu XF,He XM,et al.Age interactions in breast cancer:an analysis of a 10-year multicentre study in China[J].J Int Med Res,2012,40(3):1130-1140.
  • 8Lakhani SR,Reis-Filho JS,Fulford L,et al.Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype[J].Clin Cancer Res,2005,11(14):5175-5180.
  • 9Molyneux G,Regan J,Smalley MJ.Mammary stem cells and breast cancer[J].Cell Molecular Life Sci,2007,64(24):3248-3260.
  • 10Adedayo A Onitilo,Jessica M Engel,Robert T,et al.Breast cancer subtypes based on ER/PR and HER-2 expression:Comparison of clinicopathologic features and survival[J].Clin Med & Res,2009,7(1-2):4-13.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部